Tonight, davidlaz talks about his column on insulin. Watch the full story on LATToday on Spectrum News 1 at 7 p.m. and 10 p.m.
By introducing an"authorized generic" version of its Humalog insulin, Eli Lilly hopes to deter lawmakers and regulators from cracking down on runaway drug prices. version of its Humalog insulin for about half the current list price.
At the same time, it avoids the unpleasantness of an honest-to-goodness price cut of its name-brand drug, which would raise questions about all its pricing decisions and scare the bejeepers out of shareholders, whoAll Lilly has done, in other words, is maintain the status quo in an industry that freely, and aggressively, gouges the most vulnerable members of society.
It also might include the very same insurers and pharmacy benefit managers that complain loudly about high drug prices. Why? Because they frequently receive kickbacks from drug companies in theThese aren’t the same rebates consumers might receive in discount programs. They’re paid to the insurers and PBMs, which theoretically could pass them along to patients in the form of savings.
Greg Kueterman, a Lilly spokesman, told me the company’s generic version is intended to assist not just people without insurance but also patients with high-deductible plans who are forced to pay the list price for insulin until their deductible is met. This, too, is remarkable. Lilly appears to be defending the current system of pricing drugs at astronomic levels so that various industry players can wet their beaks.
When Humalog was introduced in 1996, it cost $21 a vial, which is about a month’s supply for many people with diabetes. The list price is now approaching $300 a vial.“The current system operates under a rebate model, and health plans can use rebates to reduce premiums for all members of their plan or fund other priorities,” Kueterman told me. “But they don’t always directly pass on to patients the rebates they receive.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
A drugmaker just released a half-price version of a life-saving diabetes medication in a bet that a lower price tag will help it escape the political crosshairsEli Lilly plans to make a generic version of its life-saving diabetes medication Humalog and sell it for half the price of the branded drug.
Read more »
Stocks making the biggest moves premarket: Tesla, AT&T, Eli Lilly & moreSome of the names on the move ahead of the open.
Read more »
Eli Lilly offers half-price insulin as politicians pressure it over drug costsDrug maker Eli Lilly & Co. will offer a half-price version of its blockbuster insulin, becoming one of the first companies to effectively cut the price of a top-selling drug amid the ongoing U.S. debate over pharmaceutical costs.
Read more »
Eli Lilly to offer half-price insulin for people with type 1 diabetesDrugmaker Eli Lilly and Co announces plans to sell a half-price version of its popular insulin injection Humalog, as it fends off criticism about rising drug prices in the US.
Read more »
Eli Lilly seeks to quell drug price anger with cheaper insulinDrugmaker Eli Lilly announced plans on Monday to sell a half-price version of it...
Read more »
Lilly to launch a half-price version of insulinU.S. drugmaker Eli Lilly plans to sell a half-price version of its Humalog insulin injection, as it fends off criticism about rising drug prices.
Read more »